Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Barrett Esophagus | 39 | 2024 | 495 | 3.110 |
Why?
|
Esophageal Neoplasms | 38 | 2024 | 1674 | 1.890 |
Why?
|
Esophagus | 27 | 2018 | 1043 | 1.590 |
Why?
|
Esophagoscopy | 21 | 2024 | 398 | 1.200 |
Why?
|
Spectrometry, Fluorescence | 8 | 2008 | 694 | 0.990 |
Why?
|
Precancerous Conditions | 18 | 2016 | 985 | 0.970 |
Why?
|
Photochemotherapy | 16 | 2011 | 830 | 0.970 |
Why?
|
Laser Therapy | 25 | 2014 | 1110 | 0.870 |
Why?
|
Lasers | 18 | 2009 | 952 | 0.750 |
Why?
|
Adenocarcinoma | 25 | 2024 | 6401 | 0.690 |
Why?
|
Computer Terminals | 1 | 2019 | 41 | 0.650 |
Why?
|
Colonic Polyps | 4 | 2019 | 557 | 0.650 |
Why?
|
Endoscopy, Gastrointestinal | 8 | 2012 | 888 | 0.620 |
Why?
|
Dihematoporphyrin Ether | 8 | 2011 | 33 | 0.600 |
Why?
|
Tomography | 6 | 2003 | 442 | 0.590 |
Why?
|
Colonoscopy | 5 | 2019 | 1410 | 0.550 |
Why?
|
Microscopy, Confocal | 8 | 2018 | 1973 | 0.550 |
Why?
|
Adenoma | 5 | 2020 | 2163 | 0.500 |
Why?
|
Photosensitizing Agents | 5 | 2011 | 630 | 0.450 |
Why?
|
Gastric Mucosa | 8 | 2018 | 602 | 0.440 |
Why?
|
Microscopy, Interference | 2 | 2003 | 35 | 0.430 |
Why?
|
Endoscopes, Gastrointestinal | 2 | 2005 | 45 | 0.410 |
Why?
|
Tomography, Optical | 2 | 2003 | 129 | 0.400 |
Why?
|
Tomography, Optical Coherence | 10 | 2021 | 2957 | 0.390 |
Why?
|
Connective Tissue | 4 | 2003 | 425 | 0.390 |
Why?
|
Cholelithiasis | 7 | 1992 | 408 | 0.370 |
Why?
|
Lithotripsy | 6 | 1992 | 141 | 0.350 |
Why?
|
Indocyanine Green | 3 | 1999 | 239 | 0.350 |
Why?
|
Light Coagulation | 5 | 1991 | 72 | 0.340 |
Why?
|
Capsule Endoscopy | 3 | 2018 | 106 | 0.340 |
Why?
|
Aminolevulinic Acid | 2 | 2002 | 150 | 0.330 |
Why?
|
Intestinal Neoplasms | 3 | 2008 | 314 | 0.310 |
Why?
|
Endoscopy, Digestive System | 8 | 2018 | 358 | 0.290 |
Why?
|
Gastrointestinal Diseases | 4 | 2013 | 1204 | 0.290 |
Why?
|
Colonic Neoplasms | 2 | 2019 | 2543 | 0.290 |
Why?
|
Metaplasia | 4 | 2024 | 326 | 0.290 |
Why?
|
Phototherapy | 2 | 2008 | 368 | 0.280 |
Why?
|
Esophageal Stenosis | 2 | 2010 | 197 | 0.280 |
Why?
|
Equipment Design | 10 | 2019 | 3530 | 0.280 |
Why?
|
Lithotripsy, Laser | 4 | 1992 | 45 | 0.270 |
Why?
|
Coloring Agents | 3 | 1999 | 564 | 0.270 |
Why?
|
Protoporphyrins | 2 | 2008 | 170 | 0.270 |
Why?
|
Burns | 8 | 1999 | 1901 | 0.270 |
Why?
|
Upper Gastrointestinal Tract | 2 | 2018 | 46 | 0.260 |
Why?
|
Bile Ducts, Intrahepatic | 3 | 2002 | 304 | 0.230 |
Why?
|
Fiber Optic Technology | 3 | 2017 | 291 | 0.230 |
Why?
|
Nitrogen | 2 | 2024 | 345 | 0.230 |
Why?
|
Microscopy | 5 | 2013 | 910 | 0.230 |
Why?
|
Intestinal Mucosa | 6 | 2018 | 3044 | 0.220 |
Why?
|
Optics and Photonics | 3 | 2003 | 307 | 0.220 |
Why?
|
Endoscopy | 6 | 2017 | 1862 | 0.200 |
Why?
|
Image Enhancement | 4 | 2009 | 2898 | 0.200 |
Why?
|
Spectrum Analysis | 3 | 2003 | 449 | 0.200 |
Why?
|
Aspirin | 4 | 2020 | 3135 | 0.200 |
Why?
|
Endoscopes | 3 | 1999 | 169 | 0.200 |
Why?
|
Eosinophilic Esophagitis | 2 | 2018 | 205 | 0.190 |
Why?
|
Microsatellite Repeats | 2 | 2001 | 785 | 0.190 |
Why?
|
Adenocarcinoma, Scirrhous | 1 | 2001 | 5 | 0.190 |
Why?
|
Cryotherapy | 2 | 2024 | 164 | 0.190 |
Why?
|
Swine | 20 | 2009 | 5997 | 0.180 |
Why?
|
Esophageal Diseases | 2 | 2010 | 168 | 0.180 |
Why?
|
Holmium | 5 | 1996 | 29 | 0.180 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 2001 | 247 | 0.170 |
Why?
|
Anticarcinogenic Agents | 2 | 2017 | 251 | 0.170 |
Why?
|
Digestive System | 1 | 2000 | 244 | 0.170 |
Why?
|
Loss of Heterozygosity | 2 | 2001 | 663 | 0.160 |
Why?
|
Gastrointestinal Tract | 2 | 2017 | 840 | 0.160 |
Why?
|
Cryosurgery | 3 | 2024 | 477 | 0.160 |
Why?
|
Feasibility Studies | 12 | 2021 | 5323 | 0.160 |
Why?
|
Stomach Diseases | 1 | 2000 | 134 | 0.160 |
Why?
|
Sensitivity and Specificity | 13 | 2018 | 14752 | 0.150 |
Why?
|
Bile Duct Neoplasms | 3 | 2002 | 615 | 0.150 |
Why?
|
Intestinal Polyps | 3 | 2008 | 105 | 0.150 |
Why?
|
Stomach | 3 | 2018 | 702 | 0.150 |
Why?
|
Aged | 47 | 2024 | 171786 | 0.150 |
Why?
|
Adenomatous Polyps | 1 | 1998 | 109 | 0.150 |
Why?
|
Gallstones | 2 | 1992 | 285 | 0.140 |
Why?
|
Biopsy | 14 | 2021 | 6805 | 0.140 |
Why?
|
Dinoprostone | 1 | 2020 | 597 | 0.140 |
Why?
|
Mucous Membrane | 5 | 2011 | 659 | 0.140 |
Why?
|
Scattering, Radiation | 6 | 2003 | 489 | 0.140 |
Why?
|
Pilot Projects | 13 | 2018 | 8748 | 0.140 |
Why?
|
Catheter Ablation | 3 | 2017 | 2780 | 0.140 |
Why?
|
Population Surveillance | 3 | 2009 | 2597 | 0.140 |
Why?
|
Genes, Tumor Suppressor | 1 | 2001 | 1064 | 0.130 |
Why?
|
Humans | 104 | 2024 | 768970 | 0.130 |
Why?
|
Male | 67 | 2024 | 365203 | 0.130 |
Why?
|
Colon | 4 | 1998 | 1803 | 0.120 |
Why?
|
Female | 68 | 2024 | 397515 | 0.120 |
Why?
|
Light | 3 | 2005 | 1355 | 0.120 |
Why?
|
Middle Aged | 48 | 2024 | 223737 | 0.120 |
Why?
|
Biopsy, Needle | 3 | 2016 | 1626 | 0.120 |
Why?
|
Stomach Neoplasms | 2 | 2006 | 1483 | 0.120 |
Why?
|
Absorption | 3 | 2003 | 244 | 0.110 |
Why?
|
Mass Screening | 2 | 2009 | 5457 | 0.110 |
Why?
|
Cholangiocarcinoma | 2 | 2002 | 562 | 0.110 |
Why?
|
Photometry | 1 | 2013 | 57 | 0.110 |
Why?
|
Cystic Duct | 1 | 1992 | 18 | 0.110 |
Why?
|
Helicobacter pylori | 2 | 2008 | 380 | 0.110 |
Why?
|
Helicobacter Infections | 2 | 2008 | 390 | 0.100 |
Why?
|
Infrared Rays | 5 | 2003 | 249 | 0.100 |
Why?
|
Aged, 80 and over | 23 | 2020 | 59739 | 0.100 |
Why?
|
Gastroesophageal Reflux | 3 | 2010 | 836 | 0.100 |
Why?
|
Skin | 9 | 1998 | 4506 | 0.100 |
Why?
|
Fluorometry | 1 | 1992 | 99 | 0.100 |
Why?
|
Gastrointestinal Hemorrhage | 3 | 2010 | 1126 | 0.100 |
Why?
|
Acoustics | 2 | 2003 | 244 | 0.090 |
Why?
|
Urinary Calculi | 2 | 1989 | 90 | 0.090 |
Why?
|
Laparoscopes | 1 | 1991 | 37 | 0.090 |
Why?
|
Sulfasalazine | 1 | 1991 | 85 | 0.090 |
Why?
|
Decision Support Techniques | 3 | 2017 | 2008 | 0.090 |
Why?
|
Gastroenterology | 1 | 2017 | 593 | 0.090 |
Why?
|
Elasticity | 2 | 2003 | 657 | 0.090 |
Why?
|
Cell Degranulation | 1 | 2011 | 277 | 0.090 |
Why?
|
Equipment Failure Analysis | 2 | 2003 | 848 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2276 | 0.090 |
Why?
|
Laser Coagulation | 1 | 1992 | 333 | 0.090 |
Why?
|
Omeprazole | 2 | 2008 | 106 | 0.090 |
Why?
|
Epithelium | 4 | 2011 | 1607 | 0.090 |
Why?
|
Obstetric Labor, Premature | 1 | 2012 | 268 | 0.090 |
Why?
|
Smoking | 6 | 2010 | 9094 | 0.090 |
Why?
|
Nasal Bone | 1 | 1990 | 58 | 0.090 |
Why?
|
Endometrium | 1 | 1992 | 406 | 0.080 |
Why?
|
Rabbits | 8 | 1998 | 4774 | 0.080 |
Why?
|
Electrocoagulation | 2 | 2006 | 157 | 0.080 |
Why?
|
Pancreas | 4 | 2006 | 1700 | 0.080 |
Why?
|
Health Education | 1 | 1996 | 1059 | 0.080 |
Why?
|
Herpesvirus 1, Equid | 1 | 1989 | 1 | 0.080 |
Why?
|
Animals | 41 | 2009 | 169335 | 0.080 |
Why?
|
Monte Carlo Method | 3 | 2004 | 1262 | 0.080 |
Why?
|
Oxyhemoglobins | 3 | 1999 | 213 | 0.080 |
Why?
|
Cyclooxygenase 2 | 1 | 2011 | 597 | 0.080 |
Why?
|
Fluorescence | 4 | 1999 | 757 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2020 | 6982 | 0.080 |
Why?
|
Sulfonamides | 2 | 2008 | 1981 | 0.080 |
Why?
|
Herpesviridae | 1 | 1989 | 104 | 0.080 |
Why?
|
Myocardial Reperfusion Injury | 1 | 1992 | 484 | 0.080 |
Why?
|
Treatment Outcome | 17 | 2024 | 65480 | 0.080 |
Why?
|
Prospective Studies | 10 | 2024 | 54962 | 0.070 |
Why?
|
Hematoporphyrin Photoradiation | 1 | 2007 | 17 | 0.070 |
Why?
|
Abscess | 1 | 2011 | 606 | 0.070 |
Why?
|
Antigens, Viral | 2 | 1989 | 996 | 0.070 |
Why?
|
Recovery of Function | 1 | 2018 | 2990 | 0.070 |
Why?
|
Markov Chains | 3 | 2012 | 979 | 0.070 |
Why?
|
Pathology, Surgical | 1 | 2009 | 150 | 0.070 |
Why?
|
Pyrazoles | 2 | 2008 | 2029 | 0.070 |
Why?
|
Phantoms, Imaging | 3 | 2013 | 2533 | 0.070 |
Why?
|
Peptic Ulcer Hemorrhage | 1 | 1987 | 47 | 0.070 |
Why?
|
Registries | 1 | 2024 | 8384 | 0.070 |
Why?
|
Chi-Square Distribution | 4 | 2018 | 3438 | 0.070 |
Why?
|
Behcet Syndrome | 1 | 2008 | 86 | 0.070 |
Why?
|
Time Factors | 14 | 2018 | 40261 | 0.070 |
Why?
|
Pathology | 1 | 2010 | 270 | 0.070 |
Why?
|
Polymorphism, Genetic | 2 | 2008 | 4251 | 0.070 |
Why?
|
Liver | 4 | 2004 | 7578 | 0.070 |
Why?
|
Adult | 23 | 2024 | 223851 | 0.070 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2007 | 106 | 0.070 |
Why?
|
Maxilla | 1 | 1990 | 489 | 0.070 |
Why?
|
Anti-Ulcer Agents | 1 | 2007 | 112 | 0.070 |
Why?
|
Eosinophils | 1 | 2011 | 953 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1941 | 0.060 |
Why?
|
Health Care Costs | 2 | 2012 | 3270 | 0.060 |
Why?
|
Physical Exertion | 2 | 1999 | 668 | 0.060 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2008 | 462 | 0.060 |
Why?
|
Defective Viruses | 1 | 1985 | 89 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2340 | 0.060 |
Why?
|
Epidermal Growth Factor | 1 | 2008 | 697 | 0.060 |
Why?
|
Sickness Impact Profile | 1 | 2006 | 299 | 0.060 |
Why?
|
Debridement | 2 | 1998 | 494 | 0.060 |
Why?
|
Ultraviolet Rays | 4 | 1995 | 1104 | 0.060 |
Why?
|
Diagnosis, Differential | 5 | 2016 | 13021 | 0.060 |
Why?
|
Neoplasm, Residual | 1 | 2010 | 1019 | 0.060 |
Why?
|
Hepatitis, Viral, Human | 1 | 1985 | 141 | 0.060 |
Why?
|
Models, Biological | 4 | 2013 | 9499 | 0.060 |
Why?
|
Intestines | 2 | 2013 | 1911 | 0.060 |
Why?
|
Osteotomy | 1 | 1990 | 838 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 3 | 2013 | 4076 | 0.060 |
Why?
|
Patient Satisfaction | 2 | 2008 | 3492 | 0.060 |
Why?
|
Health Promotion | 1 | 1996 | 2210 | 0.060 |
Why?
|
Diagnostic Imaging | 2 | 2009 | 3538 | 0.060 |
Why?
|
Forecasting | 3 | 2003 | 2945 | 0.060 |
Why?
|
Urinary Bladder | 1 | 1990 | 1162 | 0.060 |
Why?
|
Cholestasis | 1 | 1987 | 385 | 0.050 |
Why?
|
Research Design | 2 | 2017 | 6214 | 0.050 |
Why?
|
Esophagectomy | 4 | 2009 | 482 | 0.050 |
Why?
|
Odds Ratio | 3 | 2012 | 9684 | 0.050 |
Why?
|
Follow-Up Studies | 10 | 2014 | 39394 | 0.050 |
Why?
|
Optical Fibers | 1 | 2002 | 135 | 0.050 |
Why?
|
Factor Analysis, Statistical | 2 | 2018 | 1002 | 0.050 |
Why?
|
Spectrophotometry, Infrared | 2 | 1999 | 117 | 0.050 |
Why?
|
Photobiology | 1 | 2001 | 10 | 0.050 |
Why?
|
Retrospective Studies | 11 | 2017 | 81903 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2010 | 9080 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2010 | 16053 | 0.050 |
Why?
|
Models, Theoretical | 3 | 2018 | 3580 | 0.050 |
Why?
|
Neoplasm Staging | 4 | 2010 | 11262 | 0.050 |
Why?
|
Heart Valve Diseases | 1 | 1989 | 1030 | 0.050 |
Why?
|
Quality-Adjusted Life Years | 3 | 2017 | 1741 | 0.040 |
Why?
|
Skin Transplantation | 2 | 1998 | 1097 | 0.040 |
Why?
|
Forearm | 1 | 2003 | 428 | 0.040 |
Why?
|
Carbon Dioxide | 4 | 1998 | 1149 | 0.040 |
Why?
|
Bile Ducts | 1 | 2002 | 288 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 2 | 1998 | 3780 | 0.040 |
Why?
|
Mitral Valve | 1 | 1989 | 1475 | 0.040 |
Why?
|
Observer Variation | 3 | 2013 | 2623 | 0.040 |
Why?
|
Microscopy, Fluorescence | 3 | 1998 | 2635 | 0.040 |
Why?
|
Calcinosis | 1 | 1989 | 1479 | 0.040 |
Why?
|
Cost-Benefit Analysis | 5 | 2017 | 5544 | 0.040 |
Why?
|
Multidrug Resistance-Associated Proteins | 1 | 2000 | 105 | 0.040 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2000 | 139 | 0.040 |
Why?
|
Prostheses and Implants | 1 | 1987 | 1279 | 0.040 |
Why?
|
Hemoglobins | 4 | 1999 | 1531 | 0.040 |
Why?
|
Endosonography | 1 | 2004 | 626 | 0.040 |
Why?
|
Hepatitis B | 1 | 1985 | 711 | 0.040 |
Why?
|
Rats | 7 | 2008 | 23786 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 4 | 2010 | 18068 | 0.040 |
Why?
|
Algorithms | 5 | 2013 | 14201 | 0.040 |
Why?
|
Motion | 1 | 2003 | 794 | 0.040 |
Why?
|
Japan | 4 | 1999 | 1418 | 0.040 |
Why?
|
Colonoscopes | 1 | 1998 | 17 | 0.040 |
Why?
|
Sampling Studies | 2 | 2016 | 615 | 0.040 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2002 | 520 | 0.040 |
Why?
|
Aortic Valve | 1 | 1989 | 1969 | 0.040 |
Why?
|
Meperidine | 1 | 2018 | 37 | 0.040 |
Why?
|
Myocardium | 1 | 1992 | 4790 | 0.040 |
Why?
|
Respiratory Muscles | 1 | 1999 | 144 | 0.040 |
Why?
|
Logistic Models | 4 | 2014 | 13318 | 0.040 |
Why?
|
Incidence | 3 | 2017 | 21547 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2020 | 12467 | 0.040 |
Why?
|
Antibodies, Viral | 2 | 1989 | 3215 | 0.040 |
Why?
|
Hyperplasia | 4 | 2011 | 1154 | 0.040 |
Why?
|
Cartilage, Articular | 3 | 1998 | 1104 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2014 | 9442 | 0.040 |
Why?
|
Adolescent Behavior | 2 | 1999 | 1188 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2007 | 8559 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2008 | 3518 | 0.040 |
Why?
|
Aerosols | 2 | 2010 | 636 | 0.040 |
Why?
|
Blood Vessels | 1 | 2003 | 1110 | 0.040 |
Why?
|
Common Bile Duct | 2 | 1988 | 106 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2010 | 4064 | 0.030 |
Why?
|
Linear Models | 2 | 2018 | 5891 | 0.030 |
Why?
|
Reproducibility of Results | 6 | 2009 | 20245 | 0.030 |
Why?
|
Monitoring, Physiologic | 2 | 2016 | 1798 | 0.030 |
Why?
|
Dyspepsia | 2 | 2009 | 116 | 0.030 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2008 | 361 | 0.030 |
Why?
|
Calibration | 1 | 1999 | 822 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 1999 | 662 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2000 | 592 | 0.030 |
Why?
|
Immersion | 1 | 1996 | 37 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 398 | 0.030 |
Why?
|
Air | 1 | 1996 | 187 | 0.030 |
Why?
|
Hemostasis, Surgical | 1 | 1996 | 127 | 0.030 |
Why?
|
Cholangiography | 2 | 1992 | 182 | 0.030 |
Why?
|
Body Mass Index | 2 | 2010 | 13055 | 0.030 |
Why?
|
Duodenum | 1 | 2018 | 495 | 0.030 |
Why?
|
Obesity, Morbid | 1 | 2006 | 1300 | 0.030 |
Why?
|
Fentanyl | 1 | 2018 | 450 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 1995 | 877 | 0.030 |
Why?
|
Skin Physiological Phenomena | 1 | 1995 | 193 | 0.030 |
Why?
|
Synovial Membrane | 1 | 1998 | 536 | 0.030 |
Why?
|
Barium Sulfate | 1 | 1995 | 180 | 0.030 |
Why?
|
Computer Simulation | 2 | 2012 | 6291 | 0.030 |
Why?
|
Disease Progression | 4 | 2017 | 13674 | 0.030 |
Why?
|
Sigmoidoscopy | 1 | 1995 | 150 | 0.030 |
Why?
|
Enema | 1 | 1995 | 141 | 0.030 |
Why?
|
Medical Staff, Hospital | 1 | 2018 | 603 | 0.030 |
Why?
|
Risk Factors | 9 | 2017 | 74976 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2007 | 3411 | 0.030 |
Why?
|
Apoptosis | 1 | 2010 | 9527 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8664 | 0.030 |
Why?
|
Leg | 1 | 1999 | 1089 | 0.030 |
Why?
|
Chickens | 1 | 1996 | 845 | 0.030 |
Why?
|
Sodium Chloride | 1 | 1996 | 584 | 0.030 |
Why?
|
Regression Analysis | 3 | 2018 | 6346 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1408 | 0.030 |
Why?
|
Tissue Distribution | 1 | 1997 | 2298 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2008 | 10765 | 0.030 |
Why?
|
Self Concept | 1 | 1999 | 1046 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2018 | 12095 | 0.030 |
Why?
|
Case-Control Studies | 5 | 2010 | 22296 | 0.030 |
Why?
|
Video Recording | 1 | 1998 | 976 | 0.030 |
Why?
|
Hot Temperature | 2 | 1998 | 1441 | 0.030 |
Why?
|
Hernia, Hiatal | 1 | 2014 | 91 | 0.030 |
Why?
|
Cholecystostomy | 1 | 1992 | 54 | 0.030 |
Why?
|
Biophysical Phenomena | 2 | 1996 | 320 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2000 | 957 | 0.030 |
Why?
|
Single-Blind Method | 2 | 2007 | 1586 | 0.030 |
Why?
|
Ritodrine | 1 | 2012 | 4 | 0.030 |
Why?
|
Cattle | 4 | 1995 | 3819 | 0.030 |
Why?
|
Tendon Injuries | 1 | 1996 | 329 | 0.030 |
Why?
|
Tocolysis | 1 | 2012 | 18 | 0.020 |
Why?
|
Rats, Nude | 1 | 1992 | 106 | 0.020 |
Why?
|
Tocolytic Agents | 1 | 2012 | 24 | 0.020 |
Why?
|
Biophysics | 2 | 1996 | 379 | 0.020 |
Why?
|
Models, Animal | 2 | 2009 | 2122 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 1989 | 9264 | 0.020 |
Why?
|
Discriminant Analysis | 1 | 2012 | 222 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2007 | 9618 | 0.020 |
Why?
|
Tendons | 1 | 1996 | 557 | 0.020 |
Why?
|
Palliative Care | 1 | 1987 | 3644 | 0.020 |
Why?
|
Evaluation Studies as Topic | 4 | 1996 | 1629 | 0.020 |
Why?
|
Glycogen | 1 | 1992 | 252 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1445 | 0.020 |
Why?
|
Quality of Life | 2 | 2017 | 13510 | 0.020 |
Why?
|
Cohort Studies | 5 | 2018 | 41808 | 0.020 |
Why?
|
NAD | 2 | 1992 | 618 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6547 | 0.020 |
Why?
|
Wound Healing | 4 | 1998 | 2815 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2087 | 0.020 |
Why?
|
Myocardial Reperfusion | 1 | 1992 | 339 | 0.020 |
Why?
|
Prognosis | 2 | 2008 | 30046 | 0.020 |
Why?
|
Radiation Dosage | 2 | 1989 | 1970 | 0.020 |
Why?
|
Severity of Illness Index | 4 | 2012 | 15951 | 0.020 |
Why?
|
Confidence Intervals | 1 | 1996 | 2932 | 0.020 |
Why?
|
Survival Analysis | 2 | 2017 | 10115 | 0.020 |
Why?
|
Neutralization Tests | 2 | 1989 | 739 | 0.020 |
Why?
|
Ventricular Function | 1 | 1992 | 406 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11116 | 0.020 |
Why?
|
Intestine, Small | 1 | 1996 | 1218 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 1992 | 1379 | 0.020 |
Why?
|
Thermodynamics | 3 | 1996 | 591 | 0.020 |
Why?
|
Angiography | 1 | 1995 | 1598 | 0.020 |
Why?
|
Pestivirus | 1 | 1989 | 2 | 0.020 |
Why?
|
Bovine Virus Diarrhea-Mucosal Disease | 1 | 1989 | 4 | 0.020 |
Why?
|
Diarrhea Viruses, Bovine Viral | 1 | 1989 | 6 | 0.020 |
Why?
|
Cardiac Output | 1 | 1992 | 838 | 0.020 |
Why?
|
Disease Models, Animal | 5 | 2004 | 18354 | 0.020 |
Why?
|
Cattle Diseases | 1 | 1989 | 50 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 60131 | 0.020 |
Why?
|
Cholecystectomy | 1 | 1991 | 409 | 0.020 |
Why?
|
Photobleaching | 1 | 2008 | 29 | 0.020 |
Why?
|
Diverticulum | 1 | 1989 | 137 | 0.020 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2008 | 44 | 0.020 |
Why?
|
Postoperative Complications | 2 | 2010 | 15889 | 0.020 |
Why?
|
Ciliary Body | 1 | 1989 | 168 | 0.020 |
Why?
|
Phosphates | 1 | 1992 | 765 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1890 | 0.020 |
Why?
|
Precipitin Tests | 1 | 1989 | 816 | 0.020 |
Why?
|
Models, Economic | 1 | 2012 | 721 | 0.020 |
Why?
|
Age Factors | 3 | 2008 | 18435 | 0.020 |
Why?
|
Metabolic Clearance Rate | 1 | 2008 | 363 | 0.020 |
Why?
|
Hybridomas | 1 | 1989 | 444 | 0.020 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2008 | 146 | 0.020 |
Why?
|
Adolescent | 7 | 2020 | 89244 | 0.020 |
Why?
|
Physical Phenomena | 1 | 1987 | 48 | 0.020 |
Why?
|
Pancreatitis | 1 | 1994 | 1087 | 0.020 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2008 | 138 | 0.020 |
Why?
|
Sclera | 1 | 1989 | 189 | 0.020 |
Why?
|
Cell Count | 1 | 2011 | 1833 | 0.020 |
Why?
|
Esophagogastric Junction | 1 | 2009 | 351 | 0.020 |
Why?
|
Herpesviridae Infections | 1 | 1989 | 269 | 0.020 |
Why?
|
Recurrence | 2 | 2006 | 8513 | 0.020 |
Why?
|
Physics | 1 | 1987 | 92 | 0.020 |
Why?
|
Colonic Diseases | 1 | 1988 | 204 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2010 | 994 | 0.020 |
Why?
|
Cost Savings | 1 | 2012 | 915 | 0.020 |
Why?
|
Cardia | 1 | 2006 | 61 | 0.020 |
Why?
|
Immunization, Passive | 1 | 1989 | 619 | 0.020 |
Why?
|
Chemoprevention | 1 | 2008 | 326 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2004 | 5443 | 0.020 |
Why?
|
Hypertension | 1 | 2006 | 8617 | 0.020 |
Why?
|
Necrosis | 3 | 1998 | 1620 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1992 | 1617 | 0.020 |
Why?
|
Therapeutic Irrigation | 1 | 1987 | 297 | 0.020 |
Why?
|
Cricetinae | 1 | 1989 | 2423 | 0.020 |
Why?
|
Pyloric Antrum | 1 | 2005 | 66 | 0.020 |
Why?
|
Oxygen | 2 | 1998 | 4272 | 0.010 |
Why?
|
Risk Assessment | 3 | 2017 | 24333 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 1991 | 1273 | 0.010 |
Why?
|
Hospitals, Urban | 1 | 2006 | 499 | 0.010 |
Why?
|
Acute Disease | 1 | 1995 | 7245 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1994 | 2714 | 0.010 |
Why?
|
Angioplasty | 1 | 2006 | 357 | 0.010 |
Why?
|
Aorta | 1 | 1992 | 2046 | 0.010 |
Why?
|
Massachusetts | 2 | 2009 | 8894 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9377 | 0.010 |
Why?
|
Placebos | 1 | 2008 | 1667 | 0.010 |
Why?
|
Peptic Ulcer | 1 | 2005 | 215 | 0.010 |
Why?
|
Photography | 1 | 1987 | 537 | 0.010 |
Why?
|
Genotype | 2 | 2008 | 13048 | 0.010 |
Why?
|
Gastroscopy | 1 | 2005 | 213 | 0.010 |
Why?
|
Goblet Cells | 1 | 2006 | 300 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 1998 | 4978 | 0.010 |
Why?
|
Arthroscopy | 1 | 1990 | 972 | 0.010 |
Why?
|
Catheterization | 1 | 2008 | 1431 | 0.010 |
Why?
|
Chest Pain | 1 | 2010 | 1101 | 0.010 |
Why?
|
Neoplasms | 2 | 2008 | 22389 | 0.010 |
Why?
|
Safety | 1 | 2007 | 1161 | 0.010 |
Why?
|
Models, Statistical | 2 | 1995 | 5110 | 0.010 |
Why?
|
Reference Values | 1 | 1990 | 4940 | 0.010 |
Why?
|
Coronary Disease | 2 | 1999 | 5919 | 0.010 |
Why?
|
Oxygen Consumption | 2 | 1999 | 1883 | 0.010 |
Why?
|
Haplotypes | 1 | 2008 | 2725 | 0.010 |
Why?
|
Duodenoscopy | 1 | 2002 | 45 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2008 | 8144 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7453 | 0.010 |
Why?
|
Costs and Cost Analysis | 1 | 1987 | 1669 | 0.010 |
Why?
|
Hepatitis B virus | 1 | 1985 | 533 | 0.010 |
Why?
|
Carrier State | 1 | 1985 | 529 | 0.010 |
Why?
|
Bile Duct Diseases | 1 | 2002 | 98 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 1987 | 1209 | 0.010 |
Why?
|
Thermal Conductivity | 2 | 1994 | 16 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2008 | 2921 | 0.010 |
Why?
|
Glycoproteins | 1 | 1989 | 2202 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3813 | 0.010 |
Why?
|
Random Allocation | 2 | 1996 | 2394 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2009 | 3629 | 0.010 |
Why?
|
Receptor, IGF Type 2 | 1 | 2000 | 35 | 0.010 |
Why?
|
Mathematics | 2 | 1995 | 704 | 0.010 |
Why?
|
Deglutition Disorders | 1 | 2006 | 641 | 0.010 |
Why?
|
Microcirculation | 2 | 1996 | 1281 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4265 | 0.010 |
Why?
|
Reoperation | 1 | 2010 | 4342 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 6002 | 0.010 |
Why?
|
Child | 4 | 2011 | 80960 | 0.010 |
Why?
|
Lung Diseases | 1 | 1989 | 1944 | 0.010 |
Why?
|
Erythrocytes | 1 | 1988 | 2421 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 15471 | 0.010 |
Why?
|
bcl-2-Associated X Protein | 1 | 2000 | 282 | 0.010 |
Why?
|
Hyperventilation | 1 | 1999 | 78 | 0.010 |
Why?
|
Glaucoma | 1 | 1989 | 1194 | 0.010 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2000 | 306 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 1991 | 4045 | 0.010 |
Why?
|
Anaerobiosis | 1 | 1998 | 140 | 0.010 |
Why?
|
Partial Pressure | 1 | 1998 | 248 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6086 | 0.010 |
Why?
|
Muscle Fatigue | 1 | 1999 | 96 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2008 | 6320 | 0.010 |
Why?
|
Frameshift Mutation | 1 | 2000 | 393 | 0.010 |
Why?
|
Cholesterol | 1 | 1987 | 2913 | 0.010 |
Why?
|
Heart Failure | 2 | 1999 | 11879 | 0.010 |
Why?
|
Fluoroscopy | 1 | 2002 | 947 | 0.010 |
Why?
|
DNA Repair | 1 | 2007 | 2054 | 0.010 |
Why?
|
Blood Volume | 1 | 1999 | 546 | 0.010 |
Why?
|
Least-Squares Analysis | 1 | 1998 | 367 | 0.010 |
Why?
|
Heart Diseases | 1 | 1989 | 2819 | 0.010 |
Why?
|
Hemorrhage | 1 | 1988 | 3466 | 0.010 |
Why?
|
Synovitis | 1 | 1998 | 217 | 0.010 |
Why?
|
Life Expectancy | 1 | 2003 | 1249 | 0.010 |
Why?
|
Ovalbumin | 1 | 1998 | 677 | 0.010 |
Why?
|
Radiography | 1 | 2007 | 6991 | 0.010 |
Why?
|
Drug Costs | 1 | 2004 | 1198 | 0.010 |
Why?
|
Spectrophotometry | 1 | 1996 | 292 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1999 | 1500 | 0.010 |
Why?
|
Body Water | 1 | 1996 | 340 | 0.010 |
Why?
|
Inflammatory Bowel Diseases | 1 | 1989 | 2442 | 0.010 |
Why?
|
Tissue Adhesions | 1 | 1996 | 223 | 0.010 |
Why?
|
Surface Properties | 1 | 1998 | 1169 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2006 | 4541 | 0.010 |
Why?
|
Isoproterenol | 1 | 1994 | 398 | 0.010 |
Why?
|
Sex Distribution | 1 | 1999 | 2280 | 0.010 |
Why?
|
Phenylephrine | 1 | 1994 | 293 | 0.010 |
Why?
|
Energy Transfer | 1 | 1994 | 109 | 0.010 |
Why?
|
Physical Fitness | 1 | 1998 | 744 | 0.010 |
Why?
|
Hindlimb | 1 | 1996 | 516 | 0.010 |
Why?
|
Age Distribution | 1 | 1999 | 2875 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 1998 | 2126 | 0.010 |
Why?
|
Sympathetic Nervous System | 1 | 1996 | 521 | 0.010 |
Why?
|
Cardiomyopathy, Dilated | 1 | 1999 | 843 | 0.010 |
Why?
|
Decision Making | 1 | 2006 | 3953 | 0.010 |
Why?
|
Flavin-Adenine Dinucleotide | 1 | 1992 | 30 | 0.010 |
Why?
|
Sheep | 1 | 1995 | 1451 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2009 | 26395 | 0.010 |
Why?
|
Perfusion | 1 | 1996 | 1402 | 0.010 |
Why?
|
Dyspnea | 1 | 1999 | 1352 | 0.010 |
Why?
|
Arthroscopes | 1 | 1990 | 11 | 0.010 |
Why?
|
Body Temperature | 1 | 1994 | 781 | 0.010 |
Why?
|
Exercise Test | 1 | 1998 | 2187 | 0.010 |
Why?
|
Data Collection | 1 | 1999 | 3324 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1994 | 2488 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 30265 | 0.010 |
Why?
|
Biology | 1 | 1992 | 292 | 0.010 |
Why?
|
Neodymium | 1 | 1989 | 20 | 0.010 |
Why?
|
Infant | 1 | 2011 | 36556 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1998 | 6236 | 0.010 |
Why?
|
Knee Joint | 1 | 1998 | 1685 | 0.010 |
Why?
|
Anesthesia, General | 1 | 1996 | 1189 | 0.000 |
Why?
|
Child, Preschool | 1 | 2011 | 42683 | 0.000 |
Why?
|
Immune Sera | 1 | 1989 | 605 | 0.000 |
Why?
|
Kidney | 1 | 2004 | 7058 | |